Omada Health, Inc. (OMDA)
NASDAQ: OMDA · Real-Time Price · USD
14.05
+0.45 (3.31%)
At close: Mar 6, 2026, 4:00 PM EST
14.06
+0.01 (0.07%)
After-hours: Mar 6, 2026, 7:56 PM EST
Omada Health Analyst Ratings
Total Analysts
10
Consensus Rating
Buy
Price Target
$23.40
Upside
+66.55%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $28 → $22 | Strong Buy | Maintains | $28 → $22 | +56.58% | Mar 6, 2026 |
| BMO Capital | BMO Capital | Buy Maintains $27 → $18 | Buy | Maintains | $27 → $18 | +28.11% | Mar 6, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $32 → $30 | Buy | Maintains | $32 → $30 | +113.52% | Mar 6, 2026 |
| Barclays | Barclays | Buy Maintains $17 → $18 | Buy | Maintains | $17 → $18 | +28.11% | Mar 6, 2026 |
| Barclays | Barclays | Buy Maintains $22 → $17 | Buy | Maintains | $22 → $17 | +21.00% | Mar 3, 2026 |
| Needham | Needham | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +99.29% | Jan 22, 2026 |
| Wells Fargo | Wells Fargo | Hold Initiates $17 | Hold | Initiates | $17 | +21.00% | Jan 9, 2026 |
| Barclays | Barclays | Buy Maintains $29 → $22 | Buy | Maintains | $29 → $22 | +56.58% | Jan 5, 2026 |
| BMO Capital | BMO Capital | Buy Initiates $27 | Buy | Initiates | $27 | +92.17% | Nov 13, 2025 |
| Barclays | Barclays | Buy Maintains $28 → $29 | Buy | Maintains | $28 → $29 | +106.41% | Nov 7, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $27 → $28 | Buy | Maintains | $27 → $28 | +99.29% | Nov 7, 2025 |
| Needham | Needham | Strong Buy Maintains $26 → $28 | Strong Buy | Maintains | $26 → $28 | +99.29% | Nov 7, 2025 |
| Barclays | Barclays | Buy Maintains $24 → $28 | Buy | Maintains | $24 → $28 | +99.29% | Oct 22, 2025 |
| Baird | Baird | Hold Initiates $24 | Hold | Initiates | $24 | +70.82% | Sep 5, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $27 → $28 | Strong Buy | Maintains | $27 → $28 | +99.29% | Aug 8, 2025 |
| Barclays | Barclays | Buy Maintains $21 → $24 | Buy | Maintains | $21 → $24 | +70.82% | Aug 8, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.